INTERNATIONAL PATENT: NOVARTIS AG FILES APPLICATION FOR "ANTIBODIES TARGETING IL-31"

GENEVA, March 24 -- NOVARTIS AG (Lichtstrasse 354056 Basel) filed a patent application (PCT/IB2025/059075) for "ANTIBODIES TARGETING IL-31" on Sep 10, 2025. With publication no. WO/2026/058155, the details related to the patent application was published on Mar 19, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): CEBE, Regis (Novartis Pharma AGLichtstrasse 354056 Basel), KOLBINGER, Frank (Novartis Pharma AGLichtstrasse 354056 Basel), KOVARIK, Jiri (Novartis Pharma AGLichtstrasse 354056 Basel), LIU, Hejun (Novartis Institutes for BioMedical Research, Inc.10675 John Jay Hopkins DriveSan Diego, C...